Cargando…

PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A

BACKGROUND: Liver cancer is a highly malignant disease and the third leading cause of cancer death worldwide. Abnormal activation of PI3K/Akt signaling is common in cancer, but whether phosphoinositide‐3‐kinase regulatory subunit 3 (PIK3R3) plays a role in liver cancer is largely unexplored. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Weidong, Wang, Kunpeng, Mo, Jinggang, Wang, Liezhi, Song, Zhenshun, Jiang, Hao, Wang, Cong, Jin, Chong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358214/ https://www.ncbi.nlm.nih.gov/pubmed/37212524 http://dx.doi.org/10.1002/cam4.6068

Ejemplares similares

The mechanism of flavonoids from Cyclocarya paliurus on inhibiting liver cancer based on in vitro experiments and network pharmacology
por: Mo, Jinggang, et al.
Publicado: (2023)

Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
por: Zhao, Shankun, et al.
Publicado: (2021)

Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
por: Huang, Xiaoxu, et al.
Publicado: (2019)

The roles of RNA N(6)-methyladenosine in esophageal cancer
por: Teng, Chuan, et al.
Publicado: (2022)

The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms
por: Jiang, Hao, et al.
Publicado: (2023)

Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma
por: Kong, Fanhua, et al.
Publicado: (2022)

Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go
por: Wang, Kunpeng, et al.
Publicado: (2021)

Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
por: Deng, Ling, et al.
Publicado: (2019)

Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors
por: Liu, Yane, et al.
Publicado: (2022)

Imbalance of SMC1 and SMC3 Cohesins Causes Specific and Distinct Effects
por: Laugsch, Magdalena, et al.
Publicado: (2013)

Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
por: Xiao, Chunying, et al.
Publicado: (2023)

A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer
por: Zhang, Feifei, et al.
Publicado: (2019)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

miR-100-3p inhibits the adipogenic differentiation of hMSCs by targeting PIK3R1 via the PI3K/AKT signaling pathway
por: Wang, Tao, et al.
Publicado: (2020)

Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
por: Li, Guoli, et al.
Publicado: (2018)

PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis
por: Palmieri, Maria, et al.
Publicado: (2019)

AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine
por: El Ahanidi, Hajar, et al.
Publicado: (2022)

Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
por: Li, Xinran, et al.
Publicado: (2019)

Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer
por: Wu, Ziyu, et al.
Publicado: (2015)

Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer
por: Jouali, Farah, et al.
Publicado: (2018)

The SMC1-SMC3 cohesin heterodimer structures DNA through supercoiling-dependent loop formation
por: Sun, Mingxuan, et al.
Publicado: (2013)

KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania
por: Brinzan, Costel Stelian, et al.
Publicado: (2022)

A positively charged channel within the Smc1/Smc3 hinge required for sister chromatid cohesion
por: Kurze, Alexander, et al.
Publicado: (2011)

IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer
por: Zorea, Jonatan, et al.
Publicado: (2018)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer
por: Kim, Ji-Won, et al.
Publicado: (2017)

Lanthanum Chloride Causes Neurotoxicity in Rats by Upregulating miR-124 Expression and Targeting PIK3CA to Regulate the PI3K/Akt Signaling Pathway
por: Zheng, Linlin, et al.
Publicado: (2020)

Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment
por: Wang, Kunpeng, et al.
Publicado: (2021)

Roles of CDKN1B in cancer?
por: Belletti, Barbara, et al.
Publicado: (2015)

Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway
por: Chen, Zhihang, et al.
Publicado: (2020)

Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway
por: Yan, Wei, et al.
Publicado: (2021)

PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway
por: Lin, Youcheng, et al.
Publicado: (2015)

Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants
por: Tian, Wen, et al.
Publicado: (2020)

CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3
por: Yang, Lei, et al.
Publicado: (2022)

Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis via KIF5B, CYP24A1, and BTG2, Respectively
por: Lin, Weidong, et al.
Publicado: (2021)

CDKN1A upregulation and cisplatin-pemetrexed resistance in non-small cell lung cancer cells
por: Zamagni, Alice, et al.
Publicado: (2020)

PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN
por: Chong, Xiaodan, et al.
Publicado: (2022)

PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt
por: Uche, Uzodinma U., et al.
Publicado: (2018)

PIK3CD induces cell growth and invasion by activating AKT/GSK‐3β/β‐catenin signaling in colorectal cancer
por: Chen, Jing‐Song, et al.
Publicado: (2019)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5tad5rpdj7b6v6vrehpp7o4id3